Related Experiment Videos
Warfarin-induced skin necrosis: a case report.
Hani Basil Abdul-Jabar1, George Geroulakos, Nicola Philpott
1Vascular Unit, Ealing Hospital, London, UK.
Summary
Warfarin-induced skin necrosis, a rare complication of anticoagulation, occurred twice in a protein C deficient patient due to delayed diagnosis. Prompt recognition is key to managing this severe condition.
Area of Science:
- Hematology
- Dermatology
- Pharmacology
Background:
- Anticoagulation therapy with warfarin is crucial for preventing thromboembolic events.
- Warfarin-induced skin necrosis (WISN) is a rare but severe complication of warfarin therapy.
- Protein C deficiency is a known risk factor for developing warfarin-induced skin necrosis.
Observation:
- A patient with protein C deficiency experienced recurrent warfarin-induced skin necrosis.
- The complication developed twice within a short period.
- Delayed diagnosis contributed to the recurrence and severity of the condition.
Findings:
- Protein C deficiency significantly increases the risk of warfarin-induced skin necrosis.
- Timely diagnosis and management are critical for preventing severe outcomes.
- Recurrence highlights the importance of vigilant monitoring in at-risk patients.
Implications:
- Early recognition of warfarin-induced skin necrosis is vital for effective patient management.
- Prompt diagnosis and appropriate treatment can mitigate the morbidity associated with this complication.
- Understanding the role of protein C deficiency can guide preventative strategies in anticoagulated patients.